Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$209.01 - $232.56 $75,870 - $84,419
-363 Reduced 1.79%
19,896 $4.35 Million
Q3 2023

Nov 15, 2023

SELL
$201.05 - $221.7 $95,498 - $105,307
-475 Reduced 2.29%
20,259 $4.07 Million
Q2 2023

Aug 11, 2023

SELL
$211.93 - $241.33 $161,066 - $183,410
-760 Reduced 3.54%
20,734 $5 Million
Q1 2023

May 15, 2023

SELL
$213.32 - $257.83 $269,423 - $325,639
-1,263 Reduced 5.55%
21,494 $4.93 Million
Q4 2022

Feb 10, 2023

SELL
$203.72 - $248.97 $23,835 - $29,129
-117 Reduced 0.51%
22,757 $5.36 Million
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $144,391 - $184,843
-705 Reduced 2.99%
22,874 $4.68 Million
Q2 2022

Aug 11, 2022

SELL
$213.86 - $277.87 $111,421 - $144,770
-521 Reduced 2.16%
23,579 $5.53 Million
Q1 2022

May 16, 2022

SELL
$259.82 - $298.18 $195,124 - $223,933
-751 Reduced 3.02%
24,100 $6.35 Million
Q4 2021

Feb 10, 2022

SELL
$271.6 - $314.21 $101,035 - $116,886
-372 Reduced 1.47%
24,851 $7.81 Million
Q3 2021

Oct 26, 2021

SELL
$274.82 - $308.34 $212,161 - $238,038
-772 Reduced 2.97%
25,223 $7.1 Million
Q2 2021

Jul 29, 2021

BUY
$251.87 - $278.14 $138,780 - $153,255
551 Added 2.17%
25,995 $7.17 Million
Q1 2021

Apr 23, 2021

SELL
$204.88 - $255.03 $25,200 - $31,368
-123 Reduced 0.48%
25,444 $6.49 Million
Q4 2020

Feb 11, 2021

SELL
$186.91 - $214.42 $92,707 - $106,352
-496 Reduced 1.9%
25,567 $5.2 Million
Q3 2020

Nov 12, 2020

BUY
$167.03 - $201.3 $111,576 - $134,468
668 Added 2.63%
26,063 $4.91 Million
Q2 2020

Aug 13, 2020

SELL
$113.31 - $182.44 $1.47 Million - $2.37 Million
-12,988 Reduced 33.84%
25,395 $4.22 Million
Q1 2020

May 08, 2020

BUY
$104.32 - $195.28 $200,294 - $374,937
1,920 Added 5.27%
38,383 $4.85 Million
Q4 2019

Feb 11, 2020

BUY
$163.48 - $173.61 $65,718 - $69,791
402 Added 1.11%
36,463 $6.17 Million
Q3 2019

Oct 24, 2019

BUY
$159.77 - $178.1 $50,487 - $56,279
316 Added 0.88%
36,061 $6.06 Million
Q2 2019

Aug 15, 2019

BUY
$144.16 - $172.9 $15,713 - $18,846
109 Added 0.31%
35,745 $6.18 Million
Q1 2019

May 15, 2019

SELL
$123.7 - $156.3 $7,298 - $9,221
-59 Reduced 0.17%
35,636 $5.45 Million
Q4 2018

Feb 15, 2019

BUY
$120.82 - $174.09 $322,106 - $464,123
2,666 Added 8.07%
35,695 $4.51 Million
Q3 2018

Nov 15, 2018

BUY
$167.67 - $188.27 $143,357 - $160,970
855 Added 2.66%
33,029 $5.74 Million
Q2 2018

Aug 14, 2018

BUY
$160.33 - $189.41 $19,560 - $23,108
122 Added 0.38%
32,174 $5.78 Million
Q1 2018

May 15, 2018

BUY
$161.53 - $178.11 $33,921 - $37,403
210 Added 0.66%
32,052 $5.19 Million
Q4 2017

Feb 15, 2018

BUY
$147.99 - $163.95 $98,413 - $109,026
665 Added 2.13%
31,842 $5.08 Million
Q3 2017

Nov 14, 2017

BUY
$149.47 - $160.56 $4.66 Million - $5.01 Million
31,177
31,177 $4.71 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Bryn Mawr Trust CO Portfolio

Follow Bryn Mawr Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.